ClinicalTrials.Veeva

Menu

CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)

J

Johann Wolfgang Goethe University Hospital

Status

Completed

Conditions

Systemic Lupus Erythematosus

Study type

Observational

Funder types

Other

Identifiers

NCT01520155
sleffm001

Details and patient eligibility

About

The key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three groups of patients will be compared.

Full description

Key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three group of patients will be compared as followed. First group are patients with known systemic Lupus erythematodes without renal affection, second group are patients with known systemic Lupus erythematodes with renal affection and the third group are patients with a non-autoimmun chronic kidney disease

Enrollment

90 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with systemic Lupus erythematosus

Exclusion criteria

  • Patients without systemic Lupus erythematosus

Trial design

90 participants in 3 patient groups

Systemic lupus erythematosus with renal affection
Description:
30 patients will be investigated suffering from a known systemic lupus erythematosus with renal affection
Systemic lupus erythematosus without renal affection
Description:
30 patients will be investigated suffering from a known systemic lupus erythematosus without renal affection
Non-autoimmune kidney disease
Description:
Patients with non-systemic, non-autoimmune kidney disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems